Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sanofi (SNY) EBT Margin (2016 - 2026)

Sanofi's EBT Margin history spans 16 years, with the latest figure at 21.88% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 337.0% to 21.88% in Q1 2026 year-over-year; TTM through Mar 2026 was 17.34%, a 856.0% decrease, with the full-year FY2025 number at 14.15%, down 215.0% from a year prior.
  • EBT Margin hit 21.88% in Q1 2026 for Sanofi, down from 49.31% in the prior quarter.
  • Over the last five years, EBT Margin for SNY hit a ceiling of 100.74% in Q4 2022 and a floor of 15.15% in Q2 2022.
  • Historically, EBT Margin has averaged 28.81% across 5 years, with a median of 24.66% in 2025.
  • Biggest five-year swings in EBT Margin: soared 10088bps in 2022 and later tumbled -8157bps in 2023.
  • Tracing SNY's EBT Margin over 5 years: stood at 100.74% in 2022, then plummeted by -81bps to 19.16% in 2023, then skyrocketed by 34bps to 25.58% in 2024, then soared by 93bps to 49.31% in 2025, then tumbled by -56bps to 21.88% in 2026.
  • Business Quant data shows EBT Margin for SNY at 21.88% in Q1 2026, 49.31% in Q4 2025, and 24.66% in Q3 2025.